Related Experiment Videos
Interleukin 4 receptor expression on human lung tumors and normal lung
M F Tungekar1, H Turley, M S Dunnill
1Nuffield Department of Pathology, John Radcliffe Hospital, Headington, Oxford, England.
Cancer Research
|January 1, 1991
Summary
Interleukin 4 (IL-4) receptors are present on certain lung cancer cells, specifically squamous cell carcinomas and adenocarcinomas. This finding suggests a potential role for IL-4 receptors in the development of these lung tumor types.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Interleukin 4 (IL-4) is a cytokine with known roles in immune responses.
- The presence and function of IL-4 receptors in normal and cancerous lung tissue are not well understood.
- Lung cancer comprises various subtypes with distinct biological behaviors.
Purpose of the Study:
- To investigate the expression of Interleukin 4 (IL-4) receptors on different subtypes of human lung cancer.
- To determine the correlation between IL-4 receptor expression and epidermal growth factor receptor (EGFR) expression in lung tumors.
- To explore the presence of IL-4 receptors in non-neoplastic lung tissues and tumor-infiltrating immune cells.
Main Methods:
- Immunohistochemistry using monoclonal antibodies to detect IL-4 receptors and epidermal growth factor receptors (EGFR).
- Analysis of tissue samples from 29 squamous cell carcinomas, 17 adenocarcinomas, and other lung tumor types.
- Examination of non-neoplastic bronchial epithelium and tumor-infiltrating lymphocytes and macrophages.
Main Results:
- IL-4 receptors were detected on tumor cells in 10/29 squamous cell carcinomas and 6/17 adenocarcinomas.
- No IL-4 receptors were found on small cell carcinomas or carcinoid tumors.
- Most IL-4 receptor-positive tumors (all but 2) also expressed EGFR. IL-4 receptors were also found on normal bronchial epithelium and immune cells within the tumor stroma.
Conclusions:
- IL-4 receptor expression is specific to certain lung cancer subtypes, namely squamous cell carcinomas and adenocarcinomas.
- The co-expression of IL-4 receptors and EGFR in these tumors suggests potential interactions in tumor biology.
- The presence of IL-4 receptors on lung cancer cells indicates a potential therapeutic target for these specific tumor types.